
Biocept BIOC
Quarterly report 2023-Q2
added 06-06-2026
Biocept EV - Enterprise Value 2011-2026 | BIOC
Annual EV - Enterprise Value Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 M | 35.4 M | 78.9 M | 3.64 M | 85.2 M | 112 M | 6.7 B | 8.06 B | 8.45 B | 13.7 M | 28.9 M | 17.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.45 B | 3.64 M | 1.97 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 201.41 | -0.81 % | $ 22.4 B | ||
|
Celcuity
CELC
|
5.57 B | $ 87.87 | -0.77 % | $ 4.11 B | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 4.05 | -5.71 % | $ 5.39 M | ||
|
Fulgent Genetics
FLGT
|
583 M | $ 18.82 | 0.74 % | $ 579 M | ||
|
Castle Biosciences
CSTL
|
463 M | $ 20.98 | 1.35 % | $ 608 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
69.5 M | - | -61.36 % | $ 2.46 M | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 1.64 | 2.19 % | $ 7.26 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Guardant Health
GH
|
15.2 B | $ 132.35 | 0.55 % | $ 16.6 B | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 23.83 | 3.74 % | $ 1.27 B | ||
|
Illumina
ILMN
|
23.8 B | $ 166.13 | 3.21 % | $ 25.8 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M | ||
|
ICON Public Limited Company
ICLR
|
16.5 B | $ 147.98 | 1.23 % | $ 11.6 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
-2.71 B | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 161.11 | 2.62 % | $ 23.9 B | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
3.34 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
654 M | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 11.21 | 0.54 % | $ 1.44 B | ||
|
National Research Corporation
NRC
|
432 M | $ 18.77 | -0.11 % | $ 420 M | ||
|
Natera
NTRA
|
30.1 B | $ 216.16 | 1.93 % | $ 29.6 B | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 104.54 | 0.02 % | $ 7.06 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 190.24 | 1.46 % | $ 9.43 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.39 | 5.81 % | $ 417 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 468.22 | 0.19 % | $ 13.5 B | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.32 | -0.23 % | $ 400 M | ||
|
Personalis
PSNL
|
380 M | $ 10.25 | 6.88 % | $ 915 M | ||
|
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 26.74 | 1.06 % | $ 25.4 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 7.31 | 1.74 % | $ 305 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | - | - | $ 2.69 B | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 81.92 | 7.55 % | $ 4.9 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.01 | -1.95 % | $ 4.62 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 264.57 | -0.6 % | $ 22 B | ||
|
Thermo Fisher Scientific
TMO
|
186 B | $ 474.8 | 1.26 % | $ 179 B | ||
|
Trinity Biotech plc
TRIB
|
327 M | $ 0.67 | 2.52 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.22 | 1.26 % | $ 2 B | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M |